| Multiple Sclerosis |
1 |
1 |
| Disability |
0 |
0.65 |
| Intravenous |
0 |
0.46 |
| Multiple Sclerosis Relapse |
0 |
0.46 |
| Biologic Therapy |
0 |
0.43 |
| Monoclonal Antibody |
0 |
0.37 |
| Magnetic Resonance Imaging |
0 |
0.16 |
| Genomic Medicine |
0 |
0.14 |
| Influenza |
0 |
0.14 |
| Antihistamine |
0 |
0.09 |
| Brain |
0 |
0.09 |
| Cancer |
0 |
0.09 |
| Child |
0 |
0.09 |
| Cytokines |
0 |
0.09 |
| Fever |
0 |
0.09 |
| Genetics |
0 |
0.09 |
| Grant |
0 |
0.09 |
| Headache |
0 |
0.09 |
| Immunization |
0 |
0.09 |
| Immunoglobulin G (IgG) |
0 |
0.09 |
| Interference |
0 |
0.09 |
| Natural Killer (NK) Cells |
0 |
0.09 |
| Opportunistic Infection |
0 |
0.09 |
| Receptors |
0 |
0.09 |